Important pharmacy news and late-breaking industry information updated daily.
The U.S. Department of Justice on June 7 filed a brief in a district court lawsuit arguing that the Affordable Care Act's (ACA) protections for people with preexisting conditions should be invalidated at the end of 2018.
A new CDC and FDA survey reveals that the number of U.S. middle and high school students who are using tobacco products has declined, but the number is still too high.
CVS Health has named the executives who will lead the company's business units once its acquisition of Aetna is complete. Aetna will operate as a stand-alone business unit with CVS health, led by its current management, and CVS Health executives will play key roles in the combined company.
FDA reports that it has warned multiple online networks that they must stop illegally marketing unapproved and misbranded versions of opioid medications. In all, 9 online networks received warning letters, covering a total of 53 websites. "The FDA is taking additional steps to protect U.S.
NIOSH welcomes pharmacists to make needed health hazard evaluation requests
FDA has approved pegfilgrastim-jmdb (Fulphila—Mylan) as a biosimilar to pegfilgrastim (Neulasta—Amgen).
More than 10% of patients who receive opioids after surgery, endoscopic procedures experience ADEs
The results of a new study indicate that many women with early-stage breast cancer who would receive chemotherapy under current standards do not need it.
FDA Commissioner Scott Gottlieb, MD, released Thursday a statement regarding some brand-name drug makers' use of Risk Evaluation and Mitigation Strategy (REMS) requirements to block generic drugs from making a timely entry to market.
Researchers noted medication administration as main factor to possible patient harm from EHR